ChemicalBook > CAS DataBase List > Nerelimomab [usan:inn]
Nerelimomab [usan:inn]
- Product Name
- Nerelimomab [usan:inn]
- CAS No.
- 162774-06-3
- Chemical Name
- Nerelimomab [usan:inn]
- Synonyms
- Nerelimomab;Nerelimomab [usan:inn];Research Grade Nerelimomab
- CBNumber
- CB42494029
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Nerelimomab [usan:inn] Chemical Properties,Usage,Production
Uses
Monoclonal antibody.
in vivo
Nerelimomab (7.5 mg/kg, i.v. infusion) protected animals from death in a baboon model of recurrent bacteremia[1].
| Animal Model: | Baboon model of recurrent bacteremia (Challenged with E.coli)[1] |
| Dosage: | 7.5 mg/kg |
| Administration: | i.v. infusion |
| Result: | Improved organ function and attenuated cytokine and plasminogen activator inhibitor release. |
Nerelimomab [usan:inn] Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Nerelimomab [usan:inn] Suppliers
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9763
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
- Tel
- 51288865780
- sales@biosynth.com
- Country
- China
- ProdList
- 6051
- Advantage
- 58
- Tel
- 9785721070
- info@cellsciences.com
- Country
- China
- ProdList
- 6308
- Advantage
- 58
162774-06-3, Nerelimomab [usan:inn]Related Search:
Letolizumab
Nofazinlimab
Plonmarlimab
Ongericimab
dinutuximab
Solitomab
Zalifrelimab
Duvortuxizumab
Alsevalimab
Ormutivimab